| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |